Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 2262-2266

  Teuscher, Cory ^a   Butterfield, Russell J ^a   Ma, Runlin Z ^a   Zachary, James F ^a   Doerge, R W ^b   Blankenhorn, Elizabeth P ^c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b PURDUE UNIVERSITY   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; RNA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA SEQUENCE; GENE LOCUS; GENETIC POLYMORPHISM; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT;

AMINO ACID SEQUENCE; ANIMALS; CHEMOKINE CCL2; CHEMOKINES; CHEMOKINES, CC; CHROMOSOMES, HUMAN, PAIR 11; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENES, OVERLAPPING; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; MONOCYTE CHEMOATTRACTANT PROTEINS; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT, HERITABLE;

EID: 0033566679     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ebers, G. C., A. D. Sadovnick, N. J. Risch, and the Canadian Collaborative Study Group. 1995. A genetic basis for familial aggregation in multiple sclerosis. Nature 377:150.
2. Sawcer, S., P. N. Goodfellow, and A. Compston. 1997. The genetic analysis of multiple sclerosis. Trends Genet. 13:234.
3. Sundvall, M., J. Jirholt, H.-T. Yang, L. Jansson, A. Engstrom, U. Petterson, and R. Holmdahl. 1995. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat. Genet. 10:313.
4. Baker, D., O. A. Rosenwasser, J. K. O'Neill, and J. L. Turk. 1995. Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 155: 4046.
5. Encinas, J. A., M. B. Lees, R. A. Sobel, C. Symonowicz, J. M. Greer, C. L. Shovlin, H. L. Weiner, C. E. Seidman, J. G. Seidman, and V. J. Kuchroo. 1996. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J. Immunol. 157:2186.
6. Croxford, J. L., J. K. O'Neil, and D. Baker. 1997. Polygenic control of experimental allergic encephalomyelitis in Buiozzi ABH and BALB/c mice. J Neuroimmunol. 74:205.
7. Butterfield, R. J., J. D. Sudweeks, E. P. Blankenhorn, R. Korngold, J C. Marini, J. A. Todd, R. J. Roper, and C. Teuscher. 1998. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161:1860.
8. Butterfield, R. J., E. P. Blankenhorn, R. J. Roper, J. F. Zachary, R. W. Doerge, J. D. Sudweeks, J. Rose, and C. Teuscher. 1999. Genetic analysis of disease subtypes and sexual dimorphisms in mouse EAE: relapsing-remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J. Immunol. 161:1860.
9. Kuokkanen, S., M. Sundvall, J. D. Terwilliger, J. W. Tienari, R. Holmdahl, U. Pettersson, and L. Peltonen. 1996. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus eae2. Nat. Genet. 13:477.
10. Zeng, Z.-B. 1994. Precision mapping of quantitative trait loci. Genetics 136: 1457.
11. Doerge, R. W., Z.-B. Zeng, and B. S. Weir. 1997. Statistical issues in the search for genes affecting quantitative traits in experimental populations. Stat. Sci. 12: 195.
12. Zeng, Z.-B. 1993. Theoretical basis for separation of multiple linked gene effects in mapping quantitative trait loci. Proc. Natl. Acad. Sci. USA 90:10972.
13. Basten, C. J., B. S. Weir, and Z.-B. Zeng. 1997. QTL Cartographer: A Reference Manual and Tutorial for QTL Mapping. North Carolina State University, Raleigh, NC.
14. Churchill, G. A., and R. W. Doerge. 1994. Empirical thresholds for quantitative trait mapping. Genetics 138:963.
15. Avner, P. 1998. Complex traits and polygenic inheritance in the mouse. Methods 14:191.
16. Piquet-Pellorce, C., L. Grey, A. Mereau, and J. K. Heath. 1994. Are LIF and related cytokines functionally equivalent? Exp. Cell. Res. 213:340.
17. Fantuzzi, G., F. Benigni, M. Sironi, M. Conni, M. Carelli, L. Cantoni, L. Shapiro, C. A. Dinarello, J. D. Sipe, and P. Ghezzi. 1995. Ciliary neurotrophic factor (CNTF) induces serum amyloid A, hypoglycemia and anorexia, and potentiates IL-I induced corticosterone and IL-6 production in mice. Cytokine 7:150.
18. Rathjen, P. D., S. Toth, A. Willis, J. K. Heath, and A. G. Smith. 1990. Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell 62:1105.
19. Brown, M. A., D. Metcalf, and N. M. Gough. 1994. Leukemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation. Cytokine 6:300.
20. Segal, B. M., and E. M. Shevach. 1996. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184:771.
21. Glabinski, A. R., M. Tani, R. M. Streiter, V. K. Tuohy, and R. M. Ransohoff. 1997. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:617.
22. Karpus, W. J., and R. M. Ransohoff. 1998. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161:2667.
23. Godiska, R., D. Chantry, G. N. Dietsch, and P. W. Gray. 1995. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:167.
24. Kuchroo, V. K., C. A. Martin, J. M. Greer, S.-T. Ju, R. A. Sobel, and M. E. Dorf. 1993. Cytokines and adhesion molecules contribute to the ability to myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:4371.
25. McTigue, D. M., M. Tani, K. Krivacic, A. Chernosky, G. S. Kelner, D. Maciejewski, R. Maki, R. M. Ransohoff, and B. T. Stokes. 1998. Selective Chemokine mRNA accumulation in the rat spinal cord after contusion injury. J. Neurosci. Res. 53:368.
26. Miyagishi, R., S. Kikuchi, T. Fukazawa, and K. Tashiro. 1995. Macrophage inflammatory protein-1 α in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J. Neural. Sci. 129:223.
27. Hvas, J., C. McLean, J. Justesen, G. Kannourakis, L. Steinman, J. R. Oksenberg, and C. C. Bernard. Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis. Scand. J. Immunol. 46:195.
28. Simpson, J. E., J. Newcombe, M. L. Cuzner, and M. N. Woodroofe. 1998. Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 84:238.
29. McManus, C., J. W. Berman, F. M. Brett, H. Staunton, M. Farrell, and C. F. Brosnan. 1998. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J. Neuroimmunol. 86:20.
30. Hvas, J., and C. C. Bernard. 1998. Molecular detection and quantitation of the chemokine RANTES mRNA in neurological brain. APMIS 106:598.
31. Juurlink, B. H. 1998. The multiple sclerosis lesion: initiated by a localized hypoperfusion in a central nervous system where mechanisms allow leukocyte infiltration are readily unregulated? Med. Hypotheses 51:299.
32. Kivisakk, P., N. Teleshova, V. Ozenci, Y. Huang, D. Matusevicius, S. Fredrikson, M. Soderstrom, and H. Link. 1998. No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis. J. Neuroimmunol. 91:108.
33. Baggiolini, M., B. Dewald, and B. Moser. 1995. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:97.
34. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.
35. Clark-Lewis, I., C. Schumacher, M. Baggiolini, and B. Moser. 1991. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. J. Biol. Chem. 266:23128.
36. Webb, L. M. C., M. U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin-8. Proc. Natl. Acad. Sci. USA 90:7158.
37. Witt, D. P., and A. D. Lander. 1994. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4:394.
38. Tanaka, Y., D. H. Adams, and S. Shaw. 1993. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol. Today 14:111.
39. + T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible and anchored RANTES and MIP-1β. J. Immunol. 154:4899.